(19)
(11) EP 1 694 843 A1

(12)

(43) Date of publication:
30.08.2006 Bulletin 2006/35

(21) Application number: 04820427.5

(22) Date of filing: 09.12.2004
(51) International Patent Classification (IPC): 
C12N 15/11(2006.01)
G06F 17/50(2006.01)
G06N 3/10(2006.01)
(86) International application number:
PCT/EP2004/014037
(87) International publication number:
WO 2005/059132 (30.06.2005 Gazette 2005/26)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 10.12.2003 US 528430 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR 
  • NOVARTIS-PHARMA GMBH
    1230 Vienna (AT)

    AT 

(72) Inventors:
  • HALL, Jonathan
    CH-4143 Dornach (CH)
  • HUESKEN, Dieter
    79102 Freiburg i-Br. (DE)
  • LANGE, Jörg, Bernd
    79102 Freiburg i. Br. (DE)
  • NATT, Francois, Jean-Charles
    CH-4147 Aesch (CH)
  • REINHARDT, Mischa, Werner, Henri, Marie
    F-68490 Bantzenheim (FR)

(74) Representative: Crawley, Patrick Edward et al
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) RNAI POTENCY PREDICTION METHOD